Paulette: Trading suspension announcement regarding planning change of control
Securities code: 300246 Securities abbreviation: Baolai Announcement number: 2026-048 Bond code: 123065 Bond abbreviation: Baolai convertible bonds
Guangdong Baolaite Medical Technology Co., Ltd.
Announcement on trading suspension regarding planned change of control
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Special tips:
The controlling shareholder of Guangdong Baolaite Medical Technology Co., Ltd. (hereinafter referred to as the "Company") is planning a change of control. Because there are still uncertainties in relevant matters, in order to safeguard the interests of investors and avoid significant impact on the company's securities transactions, the company's stocks (securities abbreviation: Baolai, stock code: 300246) and convertible corporate bonds (bond abbreviation: Baolai Convertible Bonds, bond code: 123065) will be suspended from trading on August 3, 2026 (Monday), and the trading suspension is expected to last no more than 2 trading days. The conversion of the company's convertible corporate bonds, Baolai Convertible Bonds, into shares will be suspended.
There are still uncertainties in this planning matter. Investors are advised to pay attention to investment risks.
The company's controlling shareholder is planning a change of control. Since there are still uncertainties in relevant matters, in order to protect the interests of investors and avoid significant impact on the company's securities transactions, in accordance with the "Shenzhen Stock Exchange GEM Stock Listing Rules", "Shenzhen Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 6 - Suspension and Resumption of Trading" and other relevant regulations, the company has submitted to Shenzhen Stock Exchange According to the application of the stock exchange, the company's stocks (securities abbreviation: Baolai, stock code: 300246) and convertible corporate bonds (bond abbreviation: Baolai Convertible Bonds, bond code: 123065) will be suspended from trading on August 3, 2026 (Monday), and the trading suspension is expected to last no more than 2 trading days. The conversion of the company's convertible corporate bonds, Baolai Convertible Bonds, into shares will be suspended.
During the suspension period, the company will perform its information disclosure obligations in strict accordance with the relevant provisions and requirements of relevant laws and regulations based on the progress of the above matters. After the above matters are determined, the company will issue relevant announcements in a timely manner and apply for the resumption of trading of stocks and convertible bonds.
The company's designated media for information disclosure are Juchao Information Network (http://www.cninfo.com.cn) and China Securities Journal, Securities Times and Securities Daily. Information released by the company is subject to announcements published in the above media.
Securities code: 300246 Securities abbreviation: Baolai Announcement number: 2026-048 Bond code: 123065 Bond abbreviation: Baolai convertible bonds
Investors are kindly requested to invest rationally and pay attention to investment risks.
Announcement is hereby made.
Board of Directors of Guangdong Baolaite Medical Technology Co., Ltd.
July 31, 2026